Molecular and serologic markers of acute dengue infection in naive and flavivirus-vaccinated travelers

Diagnostic Microbiology and Infectious Disease

Volumn 65, Issue 1, 2009, Pages 42-48

  Domingo, Cristina ^a   de Ory, Fernando ^a   Sanz, Juan Carlos ^b   Reyes, Noelia ^a   Gascón, Joaquim ^c   Wichmann, Ole ^d   Puente, Sabino ^e   Schunk, Mirjam ^f   López Vélez, Rogelio ^g   Ruiz, Joaquim ^c,h   Tenorio, Antonio ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b Clinical Microbiology Unit   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^f UNIVERSITY OF MUNICH   (Germany)

^g HOSPITAL RAMÓN Y CAJAL   (Spain)

^h CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

Avidity index; Dengue infection; Flavivirus vaccinated; IgM IgG ratio; Prognostic marker; Secondary flavivirus infection; Serology

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; JAPANESE ENCEPHALITIS VACCINE; MOLECULAR MARKER; TICK BORNE ENCEPHALITIS VACCINE; YELLOW FEVER VACCINE;

ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; BLOOD SAMPLING; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; DIAGNOSTIC ACCURACY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC ENCEPHALITIS; EUROPE; FLAVIVIRUS; HUMAN; IMMUNE RESPONSE; JAPANESE ENCEPHALITIS VIRUS; MAJOR CLINICAL STUDY; METHODOLOGY; PRIORITY JOURNAL; RISK ASSESSMENT; SEROLOGY; TICK BORNE ENCEPHALITIS; TICK BORNE ENCEPHALITIS FLAVIVIRUS; TRAVEL; YELLOW FEVER; YELLOW FEVER FLAVIVIRUS;

ANTIBODIES, VIRAL; ANTIBODY AFFINITY; BIOLOGICAL MARKERS; DENGUE; DENGUE VIRUS; FLAVIVIRUS; GENETIC MARKERS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; TRAVEL; VIRAL VACCINES;

EID: 68349104964     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2009.05.004     Document Type: Article

References (23)

1. Chanama S., Anantapreecha S., A-nuegoonpipat A., Sa-gnasang A., Kurane I., and Sawanpanyalert P. Analysis of specific IgM responses in secondary dengue virus infections: levels and positive rates in comparison with primary infections. J. Clin. Virol 31 (2004) 185-189
2. de Souza V.A., Fernandes S., Araujo E.S., Tateno A.F., Oliveira O.M., Oliveira R.R., and Pannuti C.S. Use of an immunoglobulin G avidity test to discriminate between primary and secondary dengue virus infections. J. Clin. Microbiol. 42 (2004) 1782-17844
3. Doblas A., Domingo C., Bae H.G., Bohórquez C.L., de Ory F., Niedrig M., Mora D., Carrasco F.J., and Tenorio A. Yellow fever vaccine-associated viscerotropic disease and death in Spain. J. Clin. Virol. 36 (2006) 156-158
4. Domingo C., Palacios G., Niedrig M., Cabrerizo M., Jabado O., Reyes N., Lipkin W.I., and Tenorio A. A new tool for the diagnosis and molecular surveillance of dengue infections in clinical samples. Dengue Bull. 28 (2004) 87-95
5. Falconar A.K., de Plata E., and Romero-Vivas C.M. Altered enzyme-linked immunosorbent assay immunoglobulin M (IgM)/IgG optical density ratios can correctly classify all primary or secondary dengue virus infections 1 day after the onset of symptoms, when all of the viruses can be isolated. Clin. Vaccine. Immunol. 13 (2006) 1044-1051
6. Grobusch M.P., Niedrig M., Göbels K., Klipstein-Grobusch K., and Teichmann D. Evaluation of the use of RT-PCR for the early diagnosis of dengue fever. Clin. Microbiol. Infect. 12 (2006) 395-397
7. Guzmán M.G., and Kourí G. Dengue: an update. Lancet Infect. Dis. 2 (2002) 33-42
8. Guzmán M.G., and Kourí G. Dengue diagnosis, advances and challenges. J. Infect. Dis 8 (2004) 69-80
9. Halstead S.B. Dengue. Lancet 370 (2007) 1644-1652
10. Hung N.T., and Lan N.T. Improvement of case management: a key factor to reduce case-fatality rate of dengue hemorrhagic fever in southern Vietnam. Dengue Bull. 22 (2003) 144-148
11. Matheus S., Deparis X., Labeau B., Lelarge J., Morvan J., and Dussart P. Discrimination between primary and secondary dengue virus infection by an immunoglobulin G avidity test using a single acute-phase serum sample. J. Clin. Microbiol. 43 (2005) 2793-2797
12. Muñoz J., Puente S., López-Vélez R., Domingo C., Ruiz J., Ramírez G., Navarro M., de Ory F., Sanza S., Rivas P., Turrientes M.C., Tenorio A., and y Gascon J. Estudio clínico-epidemiológico del dengue importado en España. Med. Clin. (Barc) 131 (2008) 18-21
13. Pinazo M.J., Muñoz J., Radic L.B., Maretic T., Zekan S., Avsic-Zupanc T., Aymar E.S., Trilla A., and Gascon J. Imported dengue hemorrhagic fever, Europe. Emerg. Infect. Dis. 14 8 (2008) 1329-1330
14. Schilling S., Ludolfs D., Van An L., and Schmitz H. Laboratory diagnosis of primary and secondary dengue infection. J. Clin. Virol. 31 (2004) 179-184
15. Singh K., Lale A., Eong Ooi E., Chiu L., Chow V.T., Tambyah P., and Koay E.S. A prospective clinical study on the use of reverse transcription-polymerase chain reaction for the early diagnosis of Dengue fever. J. Mol. Diagn. 8 (2006) 617-620
16. Takasaki T., Nawa M., Yamada K.I., Harada M., Takeda A., and Kurane I. Evaluation of dengue IgM detection tests using sera from patients with autoimmune diseases. J. Virol. Methods 102 (2002) 61-66
17. Teichmann D., Gobels K., Niedrig M., and Grobusch M. Dengue virus infection in travelers returning to Berlin, Germany: clinical, laboratory, and diagnostic aspects. Acta. Trop. 90 (2004) 87-95
18. Teles F.R., Prazeres D.M., and Lima-Filho J.L. Trends in dengue diagnosis. Rev. Med. Virol. 15 (2005) 287-302
19. Vaughn D.W., Green S., Kalayanarooj S., Innis B.L., Nimmannitya S., Suntayakorn S., Rothman A.L., Ennis F.A., and Nisalak A. Dengue in the early febrile phase: viremia and antibody responses. Journal. of. Infectious. Dis. 176 (1997) 322-330
20. Wichmann O., Stark K., Shu P.Y., Niedrig M., Frank C., Huang J.H., and Jelinek T. Clinical features and pitfalls in the laboratory diagnosis of dengue in travelers. BMC Infect. Dis. 21 (2006) 120
21. Wichmann O., Gascon J., Schunk M., Puente S., Siikamaki H., Gjørup I., Lopez-Velez R., Clerinx J., Peyerl-Hoffmann G., Sundøy A., Genton B., Kern P., Calleri G., de Górgolas M., Mühlberger N., Jelinek T., and and European Network on Surveillance of Imported Infectious Diseases. Severe dengue virus infection in travelers: risk factors and laboratory indicators. J. Infect. Dis. 195 (2008) 1081-1083
22. Wilder-Smith S., and Schwartz E. Dengue in travelers. N. England. J. Med. . 35 (2005) 924-932
23. World Health Organization. Dengue hemorrhagic fever: diagnosis, treatment, prevention and control. 2nd ed. (1997), World Health Organization, Geneva